Literature DB >> 16189702

Molecular pathology of well-differentiated thyroid carcinomas.

Manuel Sobrinho-Simões1, Ana Preto, Ana Sofia Rocha, Patrícia Castro, Valdemar Máximo, Elsa Fonseca, Paula Soares.   

Abstract

The newly discovered molecular features of well-differentiated thyroid carcinomas derived from follicular cells are reviewed, within the frame of the 2004 WHO classification of thyroid tumours, under the following headings: "Follicular carcinoma", "Papillary carcinoma", "Follicular variant of papillary carcinoma" and "Hürthle cell tumours". A particular emphasis is put on the meaning of PAX8-PPARgamma rearrangements, RAS and BRAF mutations, and deletions and mutations of mitochondrial genes and of nuclear genes encoding for mitochondrial enzymes, for thyroid tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189702     DOI: 10.1007/s00428-005-0065-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  68 in total

Review 1.  Solitary, multiple, and familial oxyphil tumours of the thyroid gland.

Authors:  R Katoh; H R Harach; E D Williams
Journal:  J Pathol       Date:  1998-11       Impact factor: 7.996

2.  Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases.

Authors:  Z W Baloch; V A LiVolsi
Journal:  Mod Pathol       Date:  2000-08       Impact factor: 7.842

3.  Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

Authors:  M Santoro; F Carlomagno; I D Hay; M A Herrmann; M Grieco; R Melillo; M A Pierotti; I Bongarzone; G Della Porta; N Berger
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

4.  E-cadherin gene alterations are rare events in thyroid tumors.

Authors:  P Soares; G Berx; F van Roy; M Sobrinho-Simões
Journal:  Int J Cancer       Date:  1997-01-06       Impact factor: 7.396

5.  Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes.

Authors:  Patrícia Castro; Mette Eknaes; Manuel R Teixeira; Håvard E Danielsen; Paula Soares; Ragnhild A Lothe; Manuel Sobrinho-Simões
Journal:  J Pathol       Date:  2005-07       Impact factor: 7.996

6.  PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.

Authors:  Marina N Nikiforova; Paul W Biddinger; Christy M Caudill; Todd G Kroll; Yuri E Nikiforov
Journal:  Am J Surg Pathol       Date:  2002-08       Impact factor: 6.394

7.  Hürthle cell and mitochondrion-rich papillary carcinomas of the thyroid gland: an ultrastructural and immunocytochemical study.

Authors:  M A Sobrinho-Simões; J M Nesland; R Holm; M C Sambade; J V Johannessen
Journal:  Ultrastruct Pathol       Date:  1985       Impact factor: 1.094

8.  K-ras-2 G-C and G-T transversions correlate with DNA aneuploidy in colorectal adenomas.

Authors:  W Giaretti; N Pujic; A Rapallo; S Nigro; A Di Vinci; E Geido; M Risio
Journal:  Gastroenterology       Date:  1995-04       Impact factor: 22.682

9.  Specific K-ras2 mutations in human sporadic colorectal adenomas are associated with DNA near-diploid aneuploidy and inhibition of proliferation.

Authors:  W Giaretti; A Rapallo; E Geido; A Sciutto; F Merlo; M Risio; F P Rossini
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

10.  A flow cytometric deoxyribonucleic acid analysis of papillary thyroid carcinoma.

Authors:  J V Johannessen; M Sobrinho-Simões; K O Tangen; T Lindmo
Journal:  Lab Invest       Date:  1981-10       Impact factor: 5.662

View more
  18 in total

Review 1.  Diagnostic criteria in well-differentiated thyroid carcinomas.

Authors:  Elsa Fonseca; Paula Soares; Manuel Cardoso-Oliveira; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 2.  Mitochondria and cancer.

Authors:  Valdemar Máximo; Jorge Lima; Paula Soares; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2009-04-03       Impact factor: 4.064

3.  Understanding Malignancies of the Thyroid Gland: Institutional Experience.

Authors:  Jaimanti Bakshi; Sourabha Kumar Patro; Navjot Kaur; Naresh Kumar Panda; Grace Budhiraja
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-09-05

4.  A Case of Multifocal Papillary Thyroid Carcinoma Consisting of One Encapsulated Follicular Variant with BRAF K601E Mutation and Three Conventional Types with BRAF V600E Mutation.

Authors:  Wook Youn Kim; Young Sin Ko; Tae Sook Hwang; Hye Seung Han; So Dug Lim; Wan Seop Kim; Seo Young Oh
Journal:  Korean J Pathol       Date:  2013-06-25

Review 5.  Prognostic biomarkers in thyroid cancer.

Authors:  Paula Soares; Ricardo Celestino; Miguel Melo; Elsa Fonseca; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

6.  Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.

Authors:  C Eloy; J Santos; P Soares; M Sobrinho-Simões
Journal:  Virchows Arch       Date:  2011-11-12       Impact factor: 4.064

7.  The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases.

Authors:  Catarina Eloy; Joana Santos; Paula Soares; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2011-07-28       Impact factor: 4.064

8.  MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.

Authors:  Matthias Dettmer; Alexander Vogetseder; Mary Beth Durso; Holger Moch; Paul Komminoth; Aurel Perren; Yuri E Nikiforov; Marina N Nikiforova
Journal:  J Clin Endocrinol Metab       Date:  2012-11-12       Impact factor: 5.958

9.  Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Gianlorenzo Dionigi; Jean-Louis Kraimps; Kurt Werner Schmid; Michael Hermann; Sien-Yi Sheu-Grabellus; Pierre De Wailly; Anthony Beaulieu; Maria Laura Tanda; Fausto Sessa
Journal:  Langenbecks Arch Surg       Date:  2014-02       Impact factor: 3.445

10.  Combined GSTM1 and GSTT1 null genotypes are associated with a lower risk of papillary thyroid cancer.

Authors:  M C Lemos; E Coutinho; L Gomes; F Carrilho; F Rodrigues; F J Regateiro; M Carvalheiro
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.